Patients with myelodysplastic syndromes who were as old as 74 fared as well with stem cell transplantation as did patients in the 60-to-65 age range, according to a study from Dana-Farber Cancer Institute presented at the annual meeting of the American Society of Hematology.
Fuente : http://www.eurekalert.org/pub_releases/2013-12/dci...
Fuente : http://www.eurekalert.org/pub_releases/2013-12/dci...